
Overview
"Dr. Margalit is an Associate Professor of Radiation Oncology at Harvard Medical School and a member of the Head and Neck Oncology Program and the Center for Cutaneous Oncology, specializing in the treatment of tumors of the head and neck, and skin. Dr. Margalit received her medical degree from Harvard Medical School and completed her residency in radiation oncology at the Harvard Radiation Oncology Program. She completed a post-doctoral fellowship in Cancer Epidemiology and Master of Public Health in Clinical Epidemiology at the Harvard School of Public Health.Dr. Margalit teaches and mentors students from Harvard Medical School and Residents of the Harvard Radiation Oncology Program. She is an active participant on national committees of the American Society for Radiation Oncology (ASTRO), American Board of Radiology (ABR), and American Society for Clinical Oncology (ASCO). She is a senior editor for the International Journal of Radiation Oncology ● Biology ● Physics and serves as the Chair of the multi-disciplinary American Radium Society Appropriate Use Criteria Committee for Head and Neck Cancer. Dr. Margalit’s research focuses on integrating new technologies and targeted therapies to improve cure rates while minimizing side effects of cancer treatment.She is the recipient of multiple awards including the inaugural Brigham and Women's Hospital/Dana-Farber Department of Radiation Oncology Outstanding Clinician Award that recognizes ""expert patient care, demonstrates compassion and respect, and pursues excellence with integrity.""".
Dr. Margalit is highly rated in 26 conditions, according to our data. Her top areas of expertise are Merkel Cell Carcinoma, Adenoid Cystic Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), and Synovial Sarcoma.
Her clinical research consists of co-authoring 88 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
75 Francis Street, Boston, MA 02115
450 Brookline Avenue, Boston, MA 02115
450 Brookline Avenue, Boston, MA 02115
450 Brookline Avenue, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Brian Alexander is a Radiation Oncologist in Boston, Massachusetts. Dr. Alexander is highly rated in 19 conditions, according to our data. His top areas of expertise are Astrocytoma, Glioblastoma, Brain Tumor, Glioma, and Tissue Biopsy.
Brigham And Women's Hospital, Department Of Radiation Oncology
Dr. Raymond Mak is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.Dr. Mak received his undergraduate degree from Cornell University and medical degree from Harvard Medical School, trained at the Harvard Radiation Oncology Residency Program, and is board certified in Radiation Oncology.Dr. Mak has over 10 years of experience in radiation treatment of thoracic malignancies including lung cancer, mesothelioma, and thymomas, and in the clinical application of advanced radiation therapy techniques including stereotactic body radiation therapy. He has applied stereotactic body radiation therapy for novel indications including the treatment of cardiac arrhythmias. He led the implementation of MR-guided radiation therapy and adaptive radiation therapy program at BWH/DFCI in 2019 and has expertise in these innovative new treatment approaches. His research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients, and applying artificial intelligence techniques to automate radiation therapy planning and improve patient care. He has expertise in developing new methods to reduce the risk of cardiac and pulmonary toxicity for patients receiving radiation therapy. Dr. Mak is highly rated in 17 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Massachusetts General Physicians Organization Inc
Helen Shih is a Radiation Oncologist in Boston, Massachusetts. Dr. Shih is highly rated in 24 conditions, according to our data. Her top areas of expertise are Meningioma, Brain Tumor, Astrocytoma, Acoustic Neuroma, and Tissue Biopsy. Dr. Shih is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adenoid Cystic CarcinomaDr. Margalit isDistinguished. Learn about Adenoid Cystic Carcinoma.
- Head and Neck Squamous Cell Carcinoma (HNSCC)Dr. Margalit isDistinguished. Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
- Merkel Cell CarcinomaDr. Margalit isDistinguished. Learn about Merkel Cell Carcinoma.
- Advanced
- Acinic Cell Carcinoma of Salivary Glands
- Adult Soft Tissue SarcomaDr. Margalit isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Alveolar Soft Part SarcomaDr. Margalit isAdvanced. Learn about Alveolar Soft Part Sarcoma.
- Eccrine PorocarcinomaDr. Margalit isAdvanced. Learn about Eccrine Porocarcinoma.
- Epithelial-Myoepithelial CarcinomaDr. Margalit isAdvanced. Learn about Epithelial-Myoepithelial Carcinoma.
- GanglioneuroblastomaDr. Margalit isAdvanced. Learn about Ganglioneuroblastoma.
- Experienced
- Anaplastic Thyroid CancerDr. Margalit isExperienced. Learn about Anaplastic Thyroid Cancer.
- Bone TumorDr. Margalit isExperienced. Learn about Bone Tumor.
- Epithelioid SarcomaDr. Margalit isExperienced. Learn about Epithelioid Sarcoma.
- Ewing SarcomaDr. Margalit isExperienced. Learn about Ewing Sarcoma.
- FibrosarcomaDr. Margalit isExperienced. Learn about Fibrosarcoma.
- Follicular Thyroid CancerDr. Margalit isExperienced. Learn about Follicular Thyroid Cancer.
